http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004520426-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
filingDate 2001-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2004-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004520426-A
titleOfInvention Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent exclusion
abstract The present invention is a method for producing warfarin sodium from a warfarin sodium 2-propanol inclusion compound by excluding a thermally non-decomposable solvent. This solvent exclusion is performed under conditions of controlled heat transfer, whereby 2-propanol is excluded from sodium warfarin 2-propanol clathrate without decomposition of sodium warfarin or its clathrate. Heating was performed on the clathrate in an active oven at a temperature of about 100 ° C. to about 170 ° C., in air or under an inert atmosphere, and at a partial pressure ranging from relatively reduced pressure to atmospheric pressure. . The present invention also relates to pure warfarin sodium prepared according to the method of the invention and to pharmaceutical compositions containing warfarin sodium.
priorityDate 2001-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447544104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16204922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450446870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458357694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131857540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970

Total number of triples: 28.